USPTO serial 88570163
Serial No. 88570163
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GALBO, AMANDA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 88570163?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yvonne E. Tingleaf
Yvonne E. Tingleaf SCHWABE, WILLIAMSON & WYATT, P.C.1211 SW FIFTH AVENUESUITE 1900PORTLAND, OR 97204Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring analytes in interstitial fluids, blood, plasma, or other biological fluids; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring chronic health conditions; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring analytes in the human body and automatically or semi-automatically delivering medications to control the analyte concentration to be within a desired range; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring chronic health conditions and automatically or semi-automatically delivering medications to control or treat the chronic health conditions; Downloadable software in the nature of mobile applications and hardware for use in the acquisition, processing, analysis, presentation, storage, and transmission of medical and physiological data, namely, data about analytes and chronic health conditions; Downloadable software in the nature of mobile applications and hardware for use to automatically or semi-automatically deliver medications to control an individual's analyte concentration to be within a desired range or otherwise control or treat an individual's chronic health condition | ACTIVE | — |
| 010 | Medical devices used to monitor analytes in interstitial fluids, blood, plasma, and other biological fluids; Medical devices used to monitor chronic health conditions, namely, devices for monitoring glucose for medical purposes, analytes for renal function, respiratory state, pulmonary function, heart disease, cancer and psychotropic medications; Medical devices, namely, patient sensors inserted into the human body and used to monitor analytes in the human body or monitor a person's chronic health conditions, namely, for monitoring glucose for medical purposes, analytes for renal function, respiratory state and pulmonary function; Medical devices, namely, patient sensors used to monitor analytes in the human body and patient sensors to manage diabetes by automatically or semi-automatically delivering measured amounts of medications subcutaneously over time to control the analyte concentration to be within a desired range; Medical devices, namely, patient sensors used to monitor glucose, oxygen, creatinine, urea, medication, sodium, potassium, or chloride concentrations and patient sensors to manage chronic health conditions by automatically or semi-automatically delivering measured amounts of medications subcutaneously to control or treat an individual's chronic health conditions; Analyte and chronic health condition monitor accessories being devices for monitoring glucose for medical purposes, analytes for renal function, respiratory state, pulmonary function, and cancer, namely, transmitters, receivers, and medical sensor insertion devices | ACTIVE | — |
| 042 | Providing temporary use of on-line non-downloadable software for use in the acquisition, processing, analysis, presentation, storage, and transmission of medical and physiological data, namely, data about analytes and chronic health conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Waveform Technologies, Inc.
- Other trademarks owned by Waveform Technologies, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 18, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 7, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 6, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 3, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 17, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Feb 17, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 19, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 17, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 17, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 17, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 8, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 6, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 6, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 6, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 19, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 17, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 17, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 17, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 19, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 17, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 17, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 17, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 18, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 23, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 23, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 18, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 12, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 12, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 12, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 24, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2019 | NWAP | NEW APPLICATION ENTERED | — |